Alkavex, the steel trading arm of Alkagesta, took part in Metal Expo Eurasia 2026 in Istanbul, according to an account published by its parent company. The company presented its attendance as part of efforts to build relationships within the steel industry and develop its commercial presence in international markets, rather than announcing a specific transaction.
The exhibition was the eighth edition of the International Steel Products & Production Technologies Fair. Alkagesta said it occupied 42,850 square metres at the Istanbul Fair and Congress Centre and brought together steel producers, traders, technology suppliers and other industry professionals from around the world. Its account described the gathering as a leading meeting place for the iron and steel industry in Eurasia.
Deputy chief executive Nijat Osmanlı represented Alkavex during the three-day programme. According to Alkagesta, he engaged with other industry participants at an event whose programme covered sustainable production, technological change and opportunities in global steel trade. The account did not identify individual counterparties or provide details of the discussions held by the company’s representative during the fair.
The 2026 exhibition’s theme linked steel production with smarter industrial processes. Digitalisation, automation and artificial intelligence-driven production were among the areas of focus cited by Alkagesta. The company described these technologies as shaping the industry’s future, but its report did not outline any technology investments or production initiatives of its own arising from participation in the event.
For Alkavex, the emphasis was on direct contact with the market and building relationships across the international steel industry. Alkagesta linked that approach to the trading arm’s continuing commercial development overseas. The announcement provided no transaction values, trading volumes or details of new contracts, leaving its stated significance centred on industry engagement rather than disclosed commercial results.
Read the original announcement on Alkagesta.